Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization

1.

Yacoub, J.H.; Mauro, D.; Moon, A.; He, A.R.; Bashir, M.R.; Hsu, C.C.; Fishbein, T.M.; Burke, L.M.B. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation. Part two: noncurative intention. Abdom. Radiol. 2021, 1–9, doi: https://doi.org/10.1007/s00261-021-03074-z.

2.

Marrero, J.A.; Kulik, L.M.; Sirlin, C.B.; Zhu, A.X.; Finn, R.S.; Abecassis, M.M.; Roberts, L.R.; Heimbach, J.K. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2018, 68, 723–750, doi: https://doi.org/10.1002/hep.29913.

Article  PubMed  PubMed Central  Google Scholar 

3.

Hayano, K.; Lee, S.H.; Sahani, D. V. Imaging for assessment of treatment response in hepatocellular carcinoma: Current update. Indian J. Radiol. Imaging 2015, 25, 121–128, doi: https://doi.org/10.4103/0971-3026.155835.

Article  PubMed  PubMed Central  Google Scholar 

4.

Shim, J.H.; Lee, H.C.; Kim, S.O.; Shin, Y.M.; Kim, K.M.; Lim, Y.S.; Suh, D.J. Which response criteria best help predict survival of patients with hepatocellular carcinoma following chemoembolization? A validation study of old and new models. Radiology 2012, 262, 708–718, doi: https://doi.org/10.1148/radiol.11110282.

Article  PubMed  Google Scholar 

5.

Jung, E.S.; Kim, J.H.; Yoon, E.L.; Lee, H.J.; Lee, S.J.; Suh, S.J.; Lee, B.J.; Seo, Y.S.; Yim, H.J.; Seo, T.S.; et al. Comparison of the methods for tumor response assessment in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. J. Hepatol. 2013, 58, 1181–1187, doi: https://doi.org/10.1016/j.jhep.2013.01.039.

Article  PubMed  Google Scholar 

6.

Kielar, A.; Fowler, K.J.; Lewis, S.; Yaghmai, V.; Miller, F.H.; Yarmohammadi, H.; Kim, C.; Chernyak, V.; Yokoo, T.; Meyer, J.; et al. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom. Radiol. 2018, 43, 218–230, doi: https://doi.org/10.1007/s00261-017-1281-6.

Article  Google Scholar 

7.

Seo, N.; Kim, M.S.; Park, M.S.; Choi, J.Y.; Do, R.K.G.; Han, K.; Kim, M.J. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017. Eur. Radiol. 2020, 30, 261–271, doi: https://doi.org/10.1007/s00330-019-06376-5.

Article  PubMed  Google Scholar 

8.

Rosiak, G.; Podgórska, J.; Rosiak, E.; Cieszanowski, A. CT/MRI LI-RADS v2017 – Review of the guidelines. Polish J. Radiol. 2018, 83, e355–e365.

Article  Google Scholar 

9.

Elsayes, K.M.; Kielar, A.Z.; Agrons, M.M.; Szklaruk, J.; Tang, A.; Bashir, M.R.; Mitchell, D.G.; Do, R.K.; Fowler, K.J.; Chernyak, V.; et al. Liver Imaging Reporting and Data System: an expert consensus statement. J. Hepatocell. Carcinoma 2017, Volume 4, 29–39, doi: https://doi.org/10.2147/jhc.s125396.

Article  PubMed  PubMed Central  Google Scholar 

10.

Lencioni, R.; Llovet, J.M. Modified recist (mRECIST) assessment for hepatocellular carcinoma. Semin. Liver Dis. 2010, 30, 52–60.

CAS  Article  Google Scholar 

11.

Eisenhauer, E.A.; Therasse, P.; Bogaerts, J.; Schwartz, L.H.; Sargent, D.; Ford, R.; Dancey, J.; Arbuck, S.; Gwyther, S.; Mooney, M.; et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur. J. Cancer 2009, 45, 228–247, doi: https://doi.org/10.1016/j.ejca.2008.10.026.

CAS  Article  PubMed  Google Scholar 

12.

Lee, J.H.; Lee, J.M.; Kim, S.J.; Baek, J.H.; Yun, S.H.; Kim, K.W.; Han, J.K.; Choi, B.I. Enhancement patterns of hepatocellular carcinomas on multiphasic multidetector row CT: Comparison with pathological differentiation. Br. J. Radiol. 2012, 85, e573, doi: https://doi.org/10.1259/bjr/86767895.

CAS  Article  PubMed  PubMed Central  Google Scholar 

13.

Choi, J.Y.; Lee, J.M.; Sirlin, C.B. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: Part I. Development, growth, and spread: Key pathologic and imaging aspects. Radiology 2014, 272, 635–654.

Article  Google Scholar 

14.

Voizard, N.; Cerny, M.; Assad, A.; Billiard, J.S.; Olivié, D.; Perreault, P.; Kielar, A.; Do, R.K.G.; Yokoo, T.; Sirlin, C.B.; et al. Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights Imaging 2019, 10, 1–22.

Article  Google Scholar 

15.

Kim, D.W.; Choi, S.H.; Lee, J.S.; Kim, S.Y.; Lee, S.J.; Byun, J.H. Interreader Reliability of Liver Imaging Reporting and Data System Treatment Response: A Systematic Review and Meta-Analysis. Diagnostics 2021, 11, 237, doi: https://doi.org/10.3390/diagnostics11020237.

CAS  Article  PubMed  PubMed Central  Google Scholar 

16.

Youn, S.Y.; Kim, D.H.; Choi, S.H.; Kim, B.; Choi, J.-I.; Shin, Y.R.; Oh, S.N.; Rha, S.E. Diagnostic performance of Liver Imaging Reporting and Data System treatment response algorithm: a systematic review and meta-analysis. Eur. Radiol. 2021, doi: https://doi.org/10.1007/s00330-020-07464-7.

Article  PubMed  Google Scholar 

17.

Chernyak, V.; Fowler, K.J.; Kamaya, A.; Kielar, A.Z.; Elsayes, K.M.; Bashir, M.R.; Kono, Y.; Do, R.K.; Mitchell, D.G.; Singal, A.G.; et al. Liver Imaging Reporting and Data System (LI-RADS) version 2018: Imaging of hepatocellular carcinoma in at-risk patients. Radiology 2018, 289, 816–830, doi: https://doi.org/10.1148/radiol.2018181494.

Article  PubMed  Google Scholar 

18.

CT/MRI LI-RADS® v2018 CORE; 2018; Available via: https://www.acr.org/-/media/ACR/Files/RADS/LI-RADS/LIRADS_2017_Core.pdf. Accessed 11th January 2021.

19.

Cools, K.S.; Moon, A.M.; Burke, L.M.B.; McGinty, K.A.; Strassle, P.D.; Gerber, D.A. Validation of the Liver Imaging Reporting and Data System Treatment Response Criteria After Thermal Ablation for Hepatocellular Carcinoma. Liver Transplant. 2020, 26, 203–214, doi: https://doi.org/10.1002/lt.25673.

Article  Google Scholar 

20.

Kim, S.W.; Joo, I.; Kim, H.C.; Ahn, S.J.; Kang, H.J.; Jeon, S.K.; Lee, J.M. LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features. Eur. Radiol. 2020, 30, 2861–2870, doi: https://doi.org/10.1007/s00330-019-06623-9.

CAS  Article  PubMed  Google Scholar 

21.

Chaudhry, M.; McGinty, K.A.; Mervak, B.; Lerebours, R.; Li, C.; Shropshire, E.; Ronald, J.; Commander, L.; Hertel, J.; Luo, S.; et al. The LI-RADS Version 2018 MRI treatment response algorithm: Evaluation of ablated hepatocellular carcinoma. Radiology 2020, 294, 320–326, doi: https://doi.org/10.1148/radiol.2019191581.

Article  PubMed  Google Scholar 

22.

Zhang, Y.; Wang, J.; Li, H.; Zheng, T.; Jiang, H.; Li, M.; Song, B. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann. Transl. Med. 2020, 8, 388–388, doi: https://doi.org/10.21037/atm.2020.03.120.

CAS  Article  PubMed  PubMed Central  Google Scholar 

23.

Ormiston, W.E.L.; Yarmohammadi, H.; Lobaugh, S.; Schilsky, J.; Katz, S.S.; LaGratta, M.; Velayati, S.; Zheng, J.; Capanu, M.; Do, R.K.G. Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization. Abdom. Radiol. 2020, doi: https://doi.org/10.1007/s00261-020-02775-1.

Article  Google Scholar 

24.

Shropshire, E.L.; Chaudhry, M.; Miller, C.M.; Allen, B.C.; Bozdogan, E.; Cardona, D.M.; King, L.Y.; Janas, G.L.; Do, R.K.; Kim, C.Y.; et al. LI-RADS treatment response algorithm: Performance and diagnostic accuracy. Radiology 2019, 292, 226–234, doi: https://doi.org/10.1148/radiol.2019182135.

Article  PubMed  Google Scholar 

25.

Bartnik, K.; Podgórska, J.; Rosiak, G.; Korzeniowski, K.; Giziński, J.; Sajdek, M.; Wróblewski, T.; Zieniewicz, K.; Nyckowski, P.; Rowiński, O. Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study. J. Cancer Res. Clin. Oncol. 2021, doi: https://doi.org/10.1007/s00432-021-03603-9.

Article  PubMed  Google Scholar 

26.

Park, S.; Joo, I.; Ho Lee, D.; Seok Bae, J.; Yoo, J.; Kim, S.W.; Min Lee, J. Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI. Radiology 2020, 296, 554–561, doi: https://doi.org/10.1148/radiol.2020192797.

Article  PubMed  Google Scholar 

27.

Abdel Razek, A.A.K.; El-Serougy, L.G.; Saleh, G.A.; Shabana, W.; Abd El-Wahab, R. Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy. Diagn. Interv. Imaging 2020, 101, 547–553, doi: https://doi.org/10.1016/j.diii.2020.03.008.

CAS  Article  PubMed  Google Scholar 

28.

Chen, C.S.; Li, F.K.; Guo, C.Y.; Xiao, J.C.; Hu, H.T.; Cheng, H.T.; Zheng, L.; Zong, D.W.; Ma, J.L.; Jiang, L.; et al. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization. Oncotarget 2016, 7, 7241–7252, doi: https://doi.org/10.18632/oncotarget.6892.

Article  PubMed  PubMed Central  Google Scholar 

29.

Galle, P.R.; Forner, A.; Llovet, J.M.; Mazzaferro, V.; Piscaglia, F.; Raoul, J.L.; Schirmacher, P.; Vilgrain, V. EASL Clinical Practice Guidelines: Management Marees of hepatocellular carcinoma. J. Hepatol. 2018, 69, 182–236, doi: https://doi.org/10.1016/j.jhep.2018.03.019.

Article  Google Scholar 

留言 (0)

沒有登入
gif